文献
J-GLOBAL ID:201902249893267675
整理番号:19A0019392
新たに診断された転移性前立腺癌(Stampede)に対する原発腫瘍への放射線療法:無作為化対照第3相試験【JST・京大機械翻訳】
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
著者 (49件):
Parker Christopher C
(Academic Urology Unit, Royal Marsden Hospital, London, UK)
,
Parker Christopher C
(Institute of Cancer Research, London, UK)
,
James Nicholas D
(Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK)
,
Brawley Christopher D
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Clarke Noel W
(Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK)
,
Clarke Noel W
(Department of Urology, Salford Royal Hospitals, Manchester, UK)
,
Hoyle Alex P
(Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK)
,
Hoyle Alex P
(Department of Urology, Salford Royal Hospitals, Manchester, UK)
,
Ali Adnan
(Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK)
,
Ali Adnan
(The FASTMAN/Genito-Urinary Cancer Research Groups, Division of Cancer Sciences, and Belfast-Manchester Movember Centre of Excellence, Manchester Cancer Research Centre, University of Manchester, Manchester, UK)
,
Ritchie Alastair W S
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Attard Gerhardt
(UCL Cancer Institute, UCL, London, UK)
,
Chowdhury Simon
(Department of Medical Oncology, Guy’s & St Thomas’ NHS Foundation Trust, London, UK)
,
Cross William
(Department of Urology, St James University Hospital, Leeds, UK)
,
Dearnaley David P
(Academic Urology Unit, Royal Marsden Hospital, London, UK)
,
Dearnaley David P
(Institute of Cancer Research, London, UK)
,
Gillessen Silke
(Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UK)
,
Gillessen Silke
(Division of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland)
,
Gilson Clare
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Jones Robert J
(Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK)
,
Langley Ruth E
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Malik Zafar I
(The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK)
,
Mason Malcolm D
(Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK)
,
Matheson David
(Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK)
,
Millman Robin
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Russell J Martin
(Institute of Cancer Sciences, University of Glasgow, Glasgow, UK)
,
Thalmann George N
(Department of Urology, University Hospital, Inselspital, Bern, Switzerland)
,
Amos Claire L
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Alonzi Roberto
(Mount Vernon Cancer Centre, London, UK)
,
Bahl Amit
(Bristol Haematology and Oncology Centre, Bristol, UK)
,
Birtle Alison
(Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK)
,
Birtle Alison
(School of Cancer Sciences, University of Manchester, Manchester, UK)
,
Din Omar
(Department of Clinical Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK)
,
Douis Hassan
(Department of Radiology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK)
,
Eswar Chinnamani
(The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK)
,
Gale Joanna
(Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK)
,
Gannon Melissa R
(Department of Health Services Research, London School of Hygiene & Tropical Medicine, London, UK)
,
Jonnada Sai
(Department of Oncology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK)
,
Khaksar Sara
(St Luke’s Cancer Centre, Royal Surrey County Hospital, Guildford, UK)
,
Lester Jason F
(Velindre Cancer Centre, Cardiff, UK)
,
O’Sullivan Joe M
(Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast, UK)
,
Parikh Omi A
(Department of Clinical Oncology, East Lancashire Hospitals NHS Trust, Blackburn, UK)
,
Pedley Ian D
(Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK)
,
Pudney Delia M
(Clinical Oncology, Singleton Hospital, Swansea, UK)
,
Sheehan Denise J
(Exeter Oncology Centre, Royal Devon & Exeter Hospital, Exeter, UK)
,
Srihari Narayanan Nair
(Department of Oncology, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK)
,
Tran Anna T H
(Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK)
,
Parmar Mahesh K B
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
,
Sydes Matthew R
(Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
資料名:
Lancet
(Lancet)
巻:
392
号:
10162
ページ:
2353-2366
発行年:
2018年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)